Inhibrx Shares Outstanding 2020-2022 | INBX
Inhibrx shares outstanding from 2020 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Inhibrx Annual Shares Outstanding
(Millions of Shares) |
| 2021 |
38 |
| 2020 |
25 |
| 2019 |
18 |
Inhibrx Quarterly Shares Outstanding
(Millions of Shares) |
| 2022-09-30 |
39 |
| 2022-06-30 |
39 |
| 2022-03-31 |
39 |
| 2021-12-31 |
38 |
| 2021-09-30 |
38 |
| 2021-06-30 |
38 |
| 2021-03-31 |
38 |
| 2020-12-31 |
25 |
| 2020-09-30 |
27 |
| 2020-06-30 |
18 |
| 2020-03-31 |
18 |
| 2019-12-31 |
|
| 2019-09-30 |
18 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.094B |
$0.007B |
|
Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.
|
